Le Lézard
Classified in: Health
Subject: NEW PRODUCTS/SERVICES

Compass Cannabis Clinics Announces Licensed Retail Outlet in Saskatchewan


CALGARY, Alberta, June 05, 2018 (GLOBE NEWSWIRE) -- 10330698 Canada Ltd. (dba Compass Cannabis Clinics, "Compass Cannabis") is pleased to announce the success of its subsidiary, 10537888 Canada Ltd. (or "the Company" dba Starbuds Canada), in being selected by the Saskatchewan Liquor and Gaming Authority as a cannabis retailer for Weyburn, SK on June 1, 2018.

Compass Cannabis, a medical cannabis consultation company with forty clinics that are now open or confirmed across Canada, has partnered with Starbuds Colorado, one of the leading multiple state cannabis retailers in the United States. Leveraging the operational expertise of Starbuds Colorado, Starbuds Canada intends on becoming a leading retail business within Canada's cannabis industry.

Weyburn, SK, is a city located just above the North Dakota border, and aptly dubbed as "the opportunity city". The Company's successful application was supported through strategic alliances with Cannabis Compliance Inc. and David Hyde & Associates for their regulatory and security expertise. The retail location will be designed by acclaimed architecture and design firm, McKinley Burkart. Created to provide an interactive knowledge sharing experience for patrons, the cannabis retail outlet will be carefully designed to welcome the new and curious who will come to begin their education on the properties of cannabis, and the seasoned customer will come for the approachable service.

"We are thrilled to have been granted a retail license in Saskatchewan and in particular, Weyburn where one of our co-founders, Brianna Martyn, was born," Dave Martyn, the President of Compass says. "Through our numerous locations that are underway, Starbuds Canada is positioned to be a leader for cannabis retail across Canada. We look forward to opening our Weyburn location as soon as we're able."

About Compass Cannabis

Compass Cannabis is a medical cannabis consultation company whose core business is focused on providing educational and consultation services to Canadians who are able to obtain cannabis from a licensed producer under Canada's Access to Cannabis for Medical Purposes Regulations. Compass Cannabis has recently opened two new clinics in Calgary, AB, and another in Fernie, BC this month. With a rapidly growing patient base currently being served and an aggressive real estate acquisition strategy paired with Starbuds' expertise, the Company is poised to be one of the largest marijuana organizations in Canada.

Contact Information
10330698 Canada Ltd.
1650 Pandosy Street
Kelowna, British Columbia V1Y 1P7

Dave Martyn, President
[email protected]

Cautionary Statement Regarding Forward-Looking Information

This news release contains statements that constitute "forward-looking statements." Such forward looking statements involve known and unknown risks, uncertainties and other factors that may cause Compass Cannabis' actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential" and similar expressions, or that events or conditions "will," "would," "may," "could" or "should" occur.

The forward-looking information in this news release includes disclosure about the conversion and opening of future Compass Cannabis locations and the future success of the business and operations of Compass Cannabis.

Actual results may vary from the forward-looking information in this news release due to certain material risk factors. These risk factors include, but are not limited to: adverse market conditions; reliance on key and qualified personnel; the inability to convert current Compass Cannabis locations into retail cannabis retail locations; and regulatory and other risks associated with the cannabis industry in general. Compass Cannabis cautions that the foregoing list of material risk factors and assumptions is not exhaustive.

Compass Cannabis assumes no obligation to update or revise the forward-looking information in this news release, unless it is required to do so under Canadian securities legislation.


These press releases may also interest you

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....

at 17:58
More than 200 workers at American Medical Response (AMR) in Springfield and Greenfield have voted overwhelmingly to join Teamsters Local 404....

at 17:54
The American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, is celebrating National Doctors Day by highlighting three top kidney medical experts and authors known for their...

at 17:20
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on March 28, 2024. One individual was...

at 17:15
Paladin Labs Inc., a subsidiary of Endo International plc , today announced Health Canada's approval of WAKIX® (pitolisant hydrochloride tablets) for the treatment of excessive daytime sleepiness (EDS) or cataplexy in pediatric patients aged 6 years...

at 17:05
Sirona Biochem Corp. ("Sirona") announces the voting results from its Annual General Meeting of Shareholders (the "Meeting"), held in Vancouver, British Columbia on March 28, 2024. The total number of shares represented by shareholders present in...



News published on and distributed by: